Arkolith/Insider Trading/MLTX/Form 4

Reich Kristian

Chief Scientific OfficerMoonLake Immunotherapeutics (MLTX) · full profile →Form 4 · filed Oct 3, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 1, 2023Disposed to issuer(D)2.5M——0
Oct 1, 2023Disposed to issuer(D)42K——196K
Oct 1, 2023Conversion(C)42K——140K
Oct 1, 2023Conversion(C)2.5M——3.0M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 1, 2023Conversion(C)75K——0
Oct 1, 2023Conversion(C)1K——6K

Transaction Codes

D
Disposition to the issuer
C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001013762-23-001295) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML